Walden Group Healthcare M&A Blog

Integer Acquires Aran Biomedical

4/18/2022
Integer Holdings Corporation, a $1.2b device outsource manufacturer has acquired Ireland-based Aran Biomedical, a producer of proprietary medical textiles, high precision biomaterial coverings and coatings and advanced metal and polymer braiding for implantable devices. Aran Biomedical enables Integer to penetrate high growth cardiovascular...
Read More
Teamvantage Acquires MMD Medical

3/24/2022
Custom contract manufacturer and injection molder Teamvantage has acquired MMD Medical, a contract manufacturer of components for large medical OEMs. The deal will enable Teamvantage to create a one-stop-shop with differentiated precision manufacturing capabilities. Teamvantage is a portfolio company of private equity firm Graham Partners. MMD...
Read More
LumiThera Acquires Diopsys

3/10/2022
LumiThera Inc, a manufacturer of photobiomodulation (PBM) technologies that treat ocular damage and disease, has acquired Diopsys, Inc. a maker of electrophysiology (ERG) devices that analyze visual and neuro-visual disorders. The deal adds an established commercial U.S. sales force to LumiThera's EU sales team and a complimentary diagnostic and...
Read More
The Walden Group Releases 2021 Year-end Strategic Healthcare M&A Report

2/28/2022
The Walden Group is pleased to provide access to its 2021 Year-end Strategic Healthcare M&A Report, which includes: Key Market Developments The Most Important M&A Deals What the Leading CEOs are Saying Top Deals > $100m in Transaction Value Announced or Closed in 2021 Performance of Leading...
Read More
DePuy Synthes Acquires CrossRoads Extremity Systems

2/21/2022
DePuy Synthes, the orthopedics and neurosurgery division of J&J, has acquired CrossRoads® Extremity Systems from its majority investor, Healthpoint Capital. The deal adds a portfolio of implants and instruments for lower-extremity procedures. In December 2021, DePuy Synthes acquired Israeli-based OrthoSpin, maker of an robotic orthopedic...
Read More